BE539145A - - Google Patents
Info
- Publication number
- BE539145A BE539145A BE539145DA BE539145A BE 539145 A BE539145 A BE 539145A BE 539145D A BE539145D A BE 539145DA BE 539145 A BE539145 A BE 539145A
- Authority
- BE
- Belgium
- Prior art keywords
- penicillin
- salts
- water
- acid
- penicillins
- Prior art date
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 65
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 53
- 150000002960 penicillins Chemical class 0.000 claims description 49
- 229960000626 benzylpenicillin Drugs 0.000 claims description 37
- 229940049954 Penicillin Drugs 0.000 claims description 36
- 239000002253 acid Substances 0.000 claims description 35
- 239000011780 sodium chloride Substances 0.000 claims description 33
- 150000001447 alkali salts Chemical class 0.000 claims description 31
- 150000003839 salts Chemical class 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 11
- 150000007513 acids Chemical class 0.000 claims description 10
- 230000000694 effects Effects 0.000 claims description 10
- 150000007530 organic bases Chemical class 0.000 claims description 8
- 238000002560 therapeutic procedure Methods 0.000 claims description 8
- ACTNHJDHMQSOGL-UHFFFAOYSA-N N',N'-dibenzylethane-1,2-diamine Chemical compound C=1C=CC=CC=1CN(CCN)CC1=CC=CC=C1 ACTNHJDHMQSOGL-UHFFFAOYSA-N 0.000 claims description 7
- 239000007900 aqueous suspension Substances 0.000 claims description 7
- -1 salts organic bases Chemical class 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 230000002378 acidificating Effects 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 150000007522 mineralic acids Chemical class 0.000 claims description 4
- 150000007524 organic acids Chemical class 0.000 claims description 4
- 235000005985 organic acids Nutrition 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 239000012429 reaction media Substances 0.000 claims description 3
- RXMTUVIKZRXSSM-UHFFFAOYSA-N 2,2-diphenylethanamine Chemical compound C=1C=CC=CC=1C(CN)C1=CC=CC=C1 RXMTUVIKZRXSSM-UHFFFAOYSA-N 0.000 claims description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N Acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 claims description 2
- HSZCJVZRHXPCIA-UHFFFAOYSA-N N-benzyl-N-ethylaniline Chemical compound C=1C=CC=CC=1N(CC)CC1=CC=CC=C1 HSZCJVZRHXPCIA-UHFFFAOYSA-N 0.000 claims description 2
- 238000007792 addition Methods 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 241000282414 Homo sapiens Species 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000001477 organic nitrogen group Chemical group 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 28
- 239000000243 solution Substances 0.000 description 19
- 229940056360 Penicillin G Drugs 0.000 description 15
- 239000002585 base Substances 0.000 description 12
- 210000004369 Blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 210000002784 Stomach Anatomy 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
- 239000002244 precipitate Substances 0.000 description 10
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 8
- 238000001914 filtration Methods 0.000 description 8
- BPLBGHOLXOTWMN-MBNYWOFBSA-N Phenoxymethylpenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)COC1=CC=CC=C1 BPLBGHOLXOTWMN-MBNYWOFBSA-N 0.000 description 7
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 7
- 239000007924 injection Substances 0.000 description 6
- 229960004331 phenoxymethylpenicillin Drugs 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- BWLUMTFWVZZZND-UHFFFAOYSA-N N-benzyl-1-phenylmethanamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000003513 alkali Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 159000000000 sodium salts Chemical class 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 235000001258 Cinchona calisaya Nutrition 0.000 description 3
- 241000434299 Cinchona officinalis Species 0.000 description 3
- 229960000948 Quinine Drugs 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 230000000875 corresponding Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000001131 transforming Effects 0.000 description 3
- JUHORIMYRDESRB-UHFFFAOYSA-N Benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 2
- GGEOPBCYUOTKQX-UHFFFAOYSA-N N,N'-dibenzylethane-1,2-diamine;hydrochloride Chemical compound Cl.C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 GGEOPBCYUOTKQX-UHFFFAOYSA-N 0.000 description 2
- 125000005263 alkylenediamine group Chemical group 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- MGHPNCMVUAKAIE-UHFFFAOYSA-N diphenylmethanamine Chemical compound C=1C=CC=CC=1C(N)C1=CC=CC=C1 MGHPNCMVUAKAIE-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- 239000001096 (4-ethenyl-1-azabicyclo[2.2.2]octan-7-yl)-(6-methoxyquinolin-4-yl)methanol hydrochloride Substances 0.000 description 1
- LBSFSRMTJJPTCW-DSXUQNDKSA-N (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol;hydrochloride Chemical compound Cl.C([C@H]([C@H](C1)C=C)C2)CN1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LBSFSRMTJJPTCW-DSXUQNDKSA-N 0.000 description 1
- BSALESKRZUNVQU-UHFFFAOYSA-N 1-(4-aminophenyl)-2-(diethylamino)-2-hydroxypropan-1-one;hydrochloride Chemical compound Cl.CCN(CC)C(C)(O)C(=O)C1=CC=C(N)C=C1 BSALESKRZUNVQU-UHFFFAOYSA-N 0.000 description 1
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 1
- CTYOBVWQEXIGRQ-UHFFFAOYSA-N 4-phenylbut-2-enylbenzene Chemical group C=1C=CC=CC=1CC=CCC1=CC=CC=C1 CTYOBVWQEXIGRQ-UHFFFAOYSA-N 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N Amyl acetate Chemical compound CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- VGMHLKHHILSAAH-UHFFFAOYSA-N N,N'-bis(1,3-benzodioxol-5-ylmethyl)ethane-1,2-diamine Chemical compound C1=C2OCOC2=CC(CNCCNCC=2C=C3OCOC3=CC=2)=C1 VGMHLKHHILSAAH-UHFFFAOYSA-N 0.000 description 1
- XQAWOCYMTJHYGC-UHFFFAOYSA-N N,N'-bis(furan-2-ylmethyl)ethane-1,2-diamine Chemical compound C=1C=COC=1CNCCNCC1=CC=CO1 XQAWOCYMTJHYGC-UHFFFAOYSA-N 0.000 description 1
- WKNPUHTYAPKXKJ-UHFFFAOYSA-N N,N'-bis[(2,4-dichlorophenyl)methyl]ethane-1,2-diamine Chemical compound ClC1=CC(Cl)=CC=C1CNCCNCC1=CC=C(Cl)C=C1Cl WKNPUHTYAPKXKJ-UHFFFAOYSA-N 0.000 description 1
- AVHNOBYTCDKTEV-UHFFFAOYSA-N N,N'-bis[(4-methoxyphenyl)methyl]ethane-1,2-diamine Chemical compound C1=CC(OC)=CC=C1CNCCNCC1=CC=C(OC)C=C1 AVHNOBYTCDKTEV-UHFFFAOYSA-N 0.000 description 1
- JMRWVHXGVONXEZ-UHFFFAOYSA-N N,N'-dicyclohexylethane-1,2-diamine Chemical compound C1CCCCC1NCCNC1CCCCC1 JMRWVHXGVONXEZ-UHFFFAOYSA-N 0.000 description 1
- HCBIBCJNVBAKAB-UHFFFAOYSA-N Procaine hydrochloride Chemical compound Cl.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 HCBIBCJNVBAKAB-UHFFFAOYSA-N 0.000 description 1
- 229960001811 Quinine Hydrochloride Drugs 0.000 description 1
- 210000002966 Serum Anatomy 0.000 description 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
- MJPABTWCPARPBD-UHFFFAOYSA-N acetic acid;N,N'-dibenzylethane-1,2-diamine Chemical compound CC(O)=O.C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 MJPABTWCPARPBD-UHFFFAOYSA-N 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 150000008431 aliphatic amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- UPABQMWFWCMOFV-UHFFFAOYSA-N benethamine Chemical compound C=1C=CC=CC=1CNCCC1=CC=CC=C1 UPABQMWFWCMOFV-UHFFFAOYSA-N 0.000 description 1
- CIHWJRSPVJBHGT-UHFFFAOYSA-N benzhydrylazanium;chloride Chemical compound Cl.C=1C=CC=CC=1C(N)C1=CC=CC=C1 CIHWJRSPVJBHGT-UHFFFAOYSA-N 0.000 description 1
- MTRNNCLQPVCDLF-UHFFFAOYSA-N benzyl-[2-(benzylazaniumyl)ethyl]azanium;diacetate Chemical compound CC(O)=O.CC(O)=O.C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 MTRNNCLQPVCDLF-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000001747 exhibiting Effects 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000001264 neutralization Effects 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical group O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002035 prolonged Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000011593 sulfur Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE539145A true BE539145A (el) |
Family
ID=168940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE539145D BE539145A (el) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE539145A (el) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2107862A1 (el) * | 1970-09-22 | 1972-05-12 | Beecham Group Ltd |
-
0
- BE BE539145D patent/BE539145A/fr unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2107862A1 (el) * | 1970-09-22 | 1972-05-12 | Beecham Group Ltd |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0036812B1 (fr) | Nouveaux dérivés des céphalosporines, leur procédé de préparation et les médicaments utilisables comme antibiotiques qui contiennent lesdits dérivés | |
| BE1005921A4 (fr) | Utilisation en therapeutique des antagonistes des recepteurs serotoninergiques 5ht3. | |
| CA1203242A (fr) | Procede de preparation de sels derives de l'acide 3- hydroxybutanoique et d'une base organique aminee, et les sels ainsi obtenus | |
| FR2540118A1 (fr) | Nouvelles amidines | |
| US4948805A (en) | Salt of diclofenac with a pyrrolidine compound and pharmaceutical compositions which contain it | |
| EP0499544B1 (fr) | Utilisation de dérivés de tétrahydrothiénopyridine comme inhibiteurs de l'angiogénèse | |
| FR2511036A1 (fr) | Procede de preparation de derives d'insuline et produits obtenus | |
| FR2688506A1 (fr) | Procede de preparation de sels de l'acide clavulanique. | |
| WO1990005524A2 (fr) | Compositions pharmaceutiques pour la neuroprotection contenant des arylcyclohexylamines | |
| DE2216113C2 (de) | Verfahren zur Herstellung von Cephalosporinen | |
| BE539145A (el) | ||
| AP749A (en) | Clavulanic acid salts. | |
| EP0015418B1 (en) | Process for the separation of the two optical isomers of 1-(o-methoxyphenoxy)-3-isopropylamino-propan-2-ol, optical isomers obtained thereby and pharmaceutical compositions of the levorotatory antipode thereof | |
| BE897546A (fr) | Nouveaux polypeptides leur preparation et leur application comme medicaments | |
| EP0177356A2 (en) | Method for treatment of antidiuresis | |
| US4148879A (en) | Inhibition of platelet aggregation with selected phosphonic and phosphinic acid esters | |
| US3925412A (en) | Cycloamidines | |
| US4148878A (en) | Inhibition of platelet aggregation with selected phosphoric acid esters | |
| FI75169C (fi) | Foerfarande foer framstaellning av kristallint natriumcefoperazon. | |
| FR2729668A1 (fr) | Nouveaux derives de mercaptoalcanoyldipeptides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| FR2530248A1 (fr) | Nouveaux derives des cephalosporines, leur procede de preparation et medicaments antibiotiques contenant lesdits derives | |
| WO1998039286A1 (fr) | PROCEDE D'OBTENTION D'ENANTIOMERES D'ACIDES α-AMINES ET SELS DIASTEREOISOMERIQUES INTERMEDIAIRES | |
| FR2537582A1 (fr) | Nouveaux derives de l'ethylene-diamine et de la guanidine | |
| CH645901A5 (fr) | Sel sesqui-sodique d'un diacide d'oxa-beta-lactame antibiotique. | |
| CH643851A5 (fr) | Derives de la 7alpha-methoxycephalosporine et procedes pour leur preparation. |